Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
5/20/2025
WuXi Bio Transfers Leverkusen Facility to Terumo in €150 Million Deal
5/20/2025
JHM Secures Strategic Investment to Advance Synthetic Biology Innovati...
5/20/2025
Evive Bio Partners with LENIS Farma to Expand Ryzneuta® Distribution ...
5/20/2025
Pfizer Enters into $6B Exclusive Licensing Agreement with 3SBio
5/16/2025
WuXi Biologics Offloads German Plant to Terumo, Refocuses on Singapore...
5/16/2025
Viva Biotech Unveils Proprietary AI Platform to Reshape Drug Discovery
5/16/2025
US Push to Decouple from China May Spike Drug Costs, Experts Warn
5/16/2025
CSPC and Cipla Forge Exclusive U.S. Licensing Deal for Irinotecan Lipo...
5/16/2025
ArkBio Reports Positive Mid-Stage Results for Anti-Fibrotic Candidate ...
5/15/2025
Hengrui Aims to Raise $1.27B in Hong Kong IPO
5/14/2025
Chinese Drugmakers May Weather Trump's Tariff Threats With Cost Edge, ...
5/14/2025
R&D Spending Rises at 276 Chinese Drugmakers Despite Revenue Pressures
5/12/2025
Chinese Pharma Firms Expected to Withstand Trump's Drug Price Crackdow...
5/12/2025
METiS Eyes US$200M Hong Kong IPO as AI Drug Sector Heats Up
5/12/2025
Regenverse Raises ~CNY 100M in Pre-A Financing to Advance Regenerative...
5/12/2025
EndoCell Secures ~CNY 200M in Dual-Round Financing to Accelerate Cell ...
5/12/2025
China Biopharma Financing Drops in April 2025, Signals Investor Cautio...
5/10/2025
Qilu Secures Greater China Rights to Minghui's B7-H3 ADC in $38M Deal
5/10/2025
AstraZeneca Launches $475M Small Molecule Drug Plant Project in Wuxi t...
5/10/2025
Roche Invests Nearly $300M to Build Vabysmo Manufacturing Hub in Shang...
5/10/2025
~30% of Chinese Listed Pharma Cos Achieve Double Growth in Revenue and...
5/9/2025
Chinese Biotechs Turn to Switzerland as U.S. Partnerships Waver
5/9/2025
China Grants Tariff Exemptions on Select Pharmaceuticals, Microchips, ...
5/9/2025
83 Listed Chinese Pharma Firms Top 70% Margins in 2024
5/7/2025
Novo Nordisk Sees Surge in China on Wegovy Launch, GLP-1 Momentum
5/7/2025
AccurEdit's In Vivo Gene-Editing Drug ART001 Shows Sustained Efficacy ...
5/7/2025
Innovent Presents Positive Phase 2 Data for First-in-Class Bispecific ...
5/1/2025
D3 Bio Showcases Promising Next-Gen KRAS G12C Inhibitor at AACR and in...
5/1/2025
China Accelerates Investment in Africa's Burgeoning Pharma Sector
5/1/2025
CSL Reviews Potential China Tariff Relief for U.S.-Produced Albumin
Page:
4
/
23
Total number of articles:
689
:
[First]
[<<]
[2]
[3]
[4]
[5]
[6]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit